An ultrasound ‐responsive dual‐modal US/T1‐MRI contrast agent for potential diagnosis of prostate cancer
ConclusionWe synthesized MB+Fe3+MNPPs as a potential US/T1‐MRI contrast agent. This complex was applicable for diagnosing desired prostate cancer cells.Level of Evidence: 1Technical Efficacy: Stage 2J. Magn. Reson. Imaging 2018;48:1610 –1616
Source: Journal of Magnetic Resonance Imaging - Category: Radiology Authors: Young Il Yoon,
Shin ‐Woo Ha,
Hak Jong Lee Tags: Original Research Source Type: research
More News: Cancer | Cancer & Oncology | MRI Scan | Nanotechnology | Prostate Cancer | Radiology | Statistics | Study | Ultrasound